March 07, 2025CorporateUltimaster Nagomi™ and Ultimaster™ Tansei™ are now MDR certified for patients at high bleeding risk
February 27, 2025CorporateTerumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam
February 25, 2025CorporateNational Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell DiseaseThe BET on Blood for SCD collaboration aims to improve the lives of Sickle Cell Warriors by connecting healthcare providers with education about proven treatments to help manage the disease
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer
